Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Wu, JM; Wang, ZR; Hsieh, TC; Bruder, JL; Zou, JG; Huang, YZ
   Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review)
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   J.M. Wu et al., "Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review)", INT J MOL M, 8(1), 2001, pp. 3-17
2. Norred, CL; Brinker, F
   Potential coagulation effects of preoperative complementary and alternative medicines
   ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE
   
   C.L. Norred e F. Brinker, "Potential coagulation effects of preoperative complementary and alternative medicines", ALTERN TH H, 7(6), 2001, pp. 58
3. Jacobs, BR; Barr, LL; Brilli, RJ; Lyons, KA; Wong, HR
   Intracatheter nitroglycerin infusion fails to prevent catheter-related venous thrombosis: a randomized, controlled trial
   INTENSIVE CARE MEDICINE
   
   B.R. Jacobs et al., "Intracatheter nitroglycerin infusion fails to prevent catheter-related venous thrombosis: a randomized, controlled trial", INTEN CAR M, 27(1), 2001, pp. 187-192
4. Booyse, FM; Parks, DA
   Moderate wine and alcohol consumption: Beneficial effects on cardiovascular disease
   THROMBOSIS AND HAEMOSTASIS
   
   F.M. Booyse e D.A. Parks, "Moderate wine and alcohol consumption: Beneficial effects on cardiovascular disease", THROMB HAEM, 86(2), 2001, pp. 517-528
5. Basu, S; Mutschler, DK; Larsson, AO; Kiiski, R; Nordgren, A; Eriksson, MB
   Propofol (diprivan-EDTA) counteracts oxidative injury and deterioration ofthe arterial oxygen tension during experimental septic shock
   RESUSCITATION
   
   S. Basu et al., "Propofol (diprivan-EDTA) counteracts oxidative injury and deterioration ofthe arterial oxygen tension during experimental septic shock", RESUSCITAT, 50(3), 2001, pp. 341-348
6. Flesch, M; Rosenkranz, S; Erdmann, E; Bohm, M
   Alcohol and the risk of myocardial infarction
   BASIC RESEARCH IN CARDIOLOGY
   
   M. Flesch et al., "Alcohol and the risk of myocardial infarction", BAS R CARD, 96(2), 2001, pp. 128-135
7. Naderali, EK; Smith, SL; Doyle, PJ; Williams, G
   The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats
   CLINICAL SCIENCE
   
   E.K. Naderali et al., "The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats", CLIN SCI, 100(1), 2001, pp. 55-60
8. Law, NL; Ng, KFJ; Irwin, MG; Man, JSF
   Comparison of coagulation and blood loss during anaesthesia with inhaled isoflurane or intravenous propofol
   BRITISH JOURNAL OF ANAESTHESIA
   
   N.L. Law et al., "Comparison of coagulation and blood loss during anaesthesia with inhaled isoflurane or intravenous propofol", BR J ANAEST, 86(1), 2001, pp. 94-98
9. Tsujiguchi, N; Yamakage, M; Namiki, A
   Mechanisms of direct inhibitory action of propofol on uterine smooth muscle contraction in pregnant rats
   ANESTHESIOLOGY
   
   N. Tsujiguchi et al., "Mechanisms of direct inhibitory action of propofol on uterine smooth muscle contraction in pregnant rats", ANESTHESIOL, 95(5), 2001, pp. 1245-1255
10. Horn, NA; Hecker, KE; Bongers, B; Baumert, HJ; Reyle-Hahn, SM; Rossaint, R
    Coagulation assessment in healthy pigs undergoing single xenon anaesthesiaand combinations with isoflurane and sevoflurane
    ACTA ANAESTHESIOLOGICA SCANDINAVICA
    
    N.A. Horn et al., "Coagulation assessment in healthy pigs undergoing single xenon anaesthesiaand combinations with isoflurane and sevoflurane", ACT ANAE SC, 45(5), 2001, pp. 634-638
11. Wong, TM; Wu, S; Yu, XC; Li, HY
    Cardiovascular actions of Radix Stephaniae Tetrandrae: a comparison with its main component, tetrandrine
    ACTA PHARMACOLOGICA SINICA
    
    T.M. Wong et al., "Cardiovascular actions of Radix Stephaniae Tetrandrae: a comparison with its main component, tetrandrine", ACT PHAR SI, 21(12), 2000, pp. 1083-1088
12. Naderali, EK; Doyle, PJ; Williams, G
    Resveratrol induces vasorelaxation of mesenteric and uterine arteries fromfemale guinea-pigs
    CLINICAL SCIENCE
    
    E.K. Naderali et al., "Resveratrol induces vasorelaxation of mesenteric and uterine arteries fromfemale guinea-pigs", CLIN SCI, 98(5), 2000, pp. 537-543
13. Gomez, LJG; Sanchez-Muniz, FJ
    Review: Cardiovascular effect of garlic (Allium sativum).
    ARCHIVOS LATINOAMERICANOS DE NUTRICION
    
    L.J.G. Gomez e F.J. Sanchez-Muniz, "Review: Cardiovascular effect of garlic (Allium sativum).", ARCH LAT NU, 50(3), 2000, pp. 219-229
14. Ignarro, LJ
    Nitric oxide: A unique endogenous signaling molecule in vascular biology (Nobel lecture)
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    
    L.J. Ignarro, "Nitric oxide: A unique endogenous signaling molecule in vascular biology (Nobel lecture)", ANGEW CHEM, 38(13-14), 1999, pp. 1882-1892
15. Dutta-Roy, AK; Gordon, MJ; Kelly, C; Hunter, K; Crosbie, L; Knight-Carpentar, T; Williams, BC
    Inhibitory effect of Ginkgo biloba extract on human platelet aggregation
    PLATELETS
    
    A.K. Dutta-Roy et al., "Inhibitory effect of Ginkgo biloba extract on human platelet aggregation", PLATELETS, 10(5), 1999, pp. 298-305
16. Ignarro, LJ; Cirino, G; Casini, A; Napoli, C
    Nitric oxide as a signaling molecule in the vascular system: An overview
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    L.J. Ignarro et al., "Nitric oxide as a signaling molecule in the vascular system: An overview", J CARDIO PH, 34(6), 1999, pp. 879-886
17. Ignarro, LJ
    Nitric oxide: A unique endogenous signaling molecule in vascular biology
    BIOSCIENCE REPORTS
    
    L.J. Ignarro, "Nitric oxide: A unique endogenous signaling molecule in vascular biology", BIOSCI REP, 19(2), 1999, pp. 51-71
18. Wollny, T; Aiello, L; Di Tommaso, D; Bellavia, V; Rotilio, D; Donati, MB; de Gaetano, G; Iacoviello, L
    Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production
    BRITISH JOURNAL OF PHARMACOLOGY
    
    T. Wollny et al., "Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production", BR J PHARM, 127(3), 1999, pp. 747-755
19. SHAH BH; NAWAZ Z; SAEED SA; GILANI AH
    AGONIST-DEPENDENT DIFFERENTIAL-EFFECTS OF BERBERINE IN HUMAN PLATELET-AGGREGATION
    PTR. Phytotherapy research
    
    B.H. Shah et al., "AGONIST-DEPENDENT DIFFERENTIAL-EFFECTS OF BERBERINE IN HUMAN PLATELET-AGGREGATION", PTR. Phytotherapy research, 12, 1998, pp. 60-62
20. LEDEZMA E; APITZCASTRO R
    FROM FOLKLORE TO MOLECULAR MECHANISM - THE EXAMPLE OF AJOENE
    Interciencia
    
    E. Ledezma e R. Apitzcastro, "FROM FOLKLORE TO MOLECULAR MECHANISM - THE EXAMPLE OF AJOENE", Interciencia, 23(4), 1998, pp. 227
21. BOOTH BP; FUNG HL
    CONTRIBUTION OF VASCULAR TISSUE TO THE ANTIPLATELET ACTIVITY OF SODIUM-NITROPRUSSIDE
    Journal of cardiovascular pharmacology
    
    B.P. Booth e H.L. Fung, "CONTRIBUTION OF VASCULAR TISSUE TO THE ANTIPLATELET ACTIVITY OF SODIUM-NITROPRUSSIDE", Journal of cardiovascular pharmacology, 32(1), 1998, pp. 129-133
22. PAWLAK D; PAWLAK K; CHABIELSKA E; MALYSZKO J; TAKADA A; MYSLIWIEC M; BUCZKO W
    A POTENT 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT2A) ANTAGONIST, DV-7028, DELAYS ARTERIAL THROMBOSIS DEVELOPMENT IN RATS
    Thrombosis research
    
    D. Pawlak et al., "A POTENT 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT2A) ANTAGONIST, DV-7028, DELAYS ARTERIAL THROMBOSIS DEVELOPMENT IN RATS", Thrombosis research, 90(6), 1998, pp. 259-270
23. Scalbert, E; Guardiola-Lemaitre, B; Delagrange, P
    Melatonin and regulation of the cardiovascular system
    THERAPIE
    
    E. Scalbert et al., "Melatonin and regulation of the cardiovascular system", THERAPIE, 53(5), 1998, pp. 459-465
24. OREKHOV AN
    NEW PERSPECTIVES ON THE TREATMENT OF ATHEROSCLEROSIS - GARLIC PREPARATIONS
    Terapevticeskij arhiv
    
    A.N. Orekhov, "NEW PERSPECTIVES ON THE TREATMENT OF ATHEROSCLEROSIS - GARLIC PREPARATIONS", Terapevticeskij arhiv, 70(8), 1998, pp. 75-78
25. SEVERINA IS
    ROLE OF SOLUBLE GUANYLATE-CYCLASE IN THE MOLECULAR MECHANISM UNDERLYING THE PHYSIOLOGICAL-EFFECTS OF NITRIC-OXIDE
    Biochemistry
    
    I.S. Severina, "ROLE OF SOLUBLE GUANYLATE-CYCLASE IN THE MOLECULAR MECHANISM UNDERLYING THE PHYSIOLOGICAL-EFFECTS OF NITRIC-OXIDE", Biochemistry, 63(7), 1998, pp. 794-801
26. OREKHOV AN; GRUNWALD J
    EFFECTS OF GARLIC ON ATHEROSCLEROSIS
    Nutrition
    
    A.N. Orekhov e J. Grunwald, "EFFECTS OF GARLIC ON ATHEROSCLEROSIS", Nutrition, 13(7-8), 1997, pp. 656-663
27. CARDINALI DP; GOLOMBEK DA; ROSENSTEIN RE; CUTRERA RA; ESQUIFINO AI
    MELATONIN SITE AND MECHANISM OF ACTION - SINGLE OR MULTIPLE
    Journal of pineal research
    
    D.P. Cardinali et al., "MELATONIN SITE AND MECHANISM OF ACTION - SINGLE OR MULTIPLE", Journal of pineal research, 23(1), 1997, pp. 32-39
28. VEZZA R; SPINA D; TALLARIDA RJ; NATHAN M; PAGE CP; GRESELE P
    ANTIVASOCONSTRICTOR AND ANTIAGGREGATORY ACTIVITIES OF PICOTAMIDE UNRELATED TO THROMBOXANE A(2) ANTAGONISM
    Thrombosis and haemostasis
    
    R. Vezza et al., "ANTIVASOCONSTRICTOR AND ANTIAGGREGATORY ACTIVITIES OF PICOTAMIDE UNRELATED TO THROMBOXANE A(2) ANTAGONISM", Thrombosis and haemostasis, 78(5), 1997, pp. 1385-1391
29. CARROLL RC; WANG XF; LANZA F; STEINER B; KOUNS WC
    BLOCKING PLATELET-AGGREGATION INHIBITS THROMBOXANE A(2) FORMATION BY LOW-DOSE AGONISTS BUT DOES NOT INHIBIT PHOSPHORYLATION AND ACTIVATION OF CYTOSOLIC PHOSPHOLIPASE A(2)
    Thrombosis research
    
    R.C. Carroll et al., "BLOCKING PLATELET-AGGREGATION INHIBITS THROMBOXANE A(2) FORMATION BY LOW-DOSE AGONISTS BUT DOES NOT INHIBIT PHOSPHORYLATION AND ACTIVATION OF CYTOSOLIC PHOSPHOLIPASE A(2)", Thrombosis research, 88(2), 1997, pp. 109-125
30. BOOTH BP; NOLAN TD; FUNG HL
    NITROGLYCERIN-INHIBITED WHOLE-BLOOD AGGREGATION IS PARTIALLY MEDIATEDBY CALCITONIN-GENE-RELATED PEPTIDE - A NEUROGENIC MECHANISM
    British Journal of Pharmacology
    
    B.P. Booth et al., "NITROGLYCERIN-INHIBITED WHOLE-BLOOD AGGREGATION IS PARTIALLY MEDIATEDBY CALCITONIN-GENE-RELATED PEPTIDE - A NEUROGENIC MECHANISM", British Journal of Pharmacology, 122(3), 1997, pp. 577-583
31. GARGOURI Y; RANSAC S; VERGER R
    COVALENT INHIBITION OF DIGESTIVE LIPASES - AN IN-VITRO STUDY
    Biochimica et biophysica acta, L. Lipids and lipid metabolism
    
    Y. Gargouri et al., "COVALENT INHIBITION OF DIGESTIVE LIPASES - AN IN-VITRO STUDY", Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1344(1), 1997, pp. 6-37
32. AGARWAL KC
    THERAPEUTIC ACTIONS OF GARLIC CONSTITUENTS
    Medicinal research reviews
    
    K.C. Agarwal, "THERAPEUTIC ACTIONS OF GARLIC CONSTITUENTS", Medicinal research reviews, 16(1), 1996, pp. 111-124
33. SCHLUTER H; TEPEL M; ZIDEK W
    VASCULAR ACTIONS OF DIADENOSINE PHOSPHATES
    Journal of autonomic pharmacology
    
    H. Schluter et al., "VASCULAR ACTIONS OF DIADENOSINE PHOSPHATES", Journal of autonomic pharmacology, 16(6), 1996, pp. 357-362
34. COOKE JP
    ROLE OF NITRIC-OXIDE IN PROGRESSION AND REGRESSION OF ATHEROSCLEROSIS
    Western journal of medicine
    
    J.P. Cooke, "ROLE OF NITRIC-OXIDE IN PROGRESSION AND REGRESSION OF ATHEROSCLEROSIS", Western journal of medicine, 164(5), 1996, pp. 419-424
35. IGNARRO LJ
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF NITRIC-OXIDE
    Kidney international
    
    L.J. Ignarro, "PHYSIOLOGY AND PATHOPHYSIOLOGY OF NITRIC-OXIDE", Kidney international, 1996, pp. 2-5
36. HATANAKA K; NOMURA T; HIDAKA K; TAKEUCHI H; YATSUGI S; FUJII M; YAMAGUCHI T
    BIOCHEMICAL PROFILE OF YM992, A NOVEL SELECTIVE SEROTONIN REUPTAKE INHIBITOR WITH 5-HT2A RECEPTOR ANTAGONISTIC ACTIVITY
    Neuropharmacology
    
    K. Hatanaka et al., "BIOCHEMICAL PROFILE OF YM992, A NOVEL SELECTIVE SEROTONIN REUPTAKE INHIBITOR WITH 5-HT2A RECEPTOR ANTAGONISTIC ACTIVITY", Neuropharmacology, 35(11), 1996, pp. 1621-1626
37. UPCHURCH GR; WELCH GN; LOSCALZO J
    HOMOCYSTEINE, EDRF AND ENDOTHELIAL FUNCTION
    The Journal of nutrition
    
    G.R. Upchurch et al., "HOMOCYSTEINE, EDRF AND ENDOTHELIAL FUNCTION", The Journal of nutrition, 126(4), 1996, pp. 1290-1294
38. HILL DJ; ROWLEY AF
    THE THROMBOXANE MIMETIC, U-46619, INDUCES THE AGGREGATION OF FISH THROMBOCYTES
    British Journal of Haematology
    
    D.J. Hill e A.F. Rowley, "THE THROMBOXANE MIMETIC, U-46619, INDUCES THE AGGREGATION OF FISH THROMBOCYTES", British Journal of Haematology, 92(1), 1996, pp. 200-211
39. LOSASSO C; LOFFREDA A; ANGRISANI M; CONTALDI C; CAZZOLA M; ROSSI F
    EFFECTS OF LOMEFLOXACIN AND SPARFLOXACIN ON HUMAN PLATELET-AGGREGATION
    Journal of chemotherapy
    
    C. Losasso et al., "EFFECTS OF LOMEFLOXACIN AND SPARFLOXACIN ON HUMAN PLATELET-AGGREGATION", Journal of chemotherapy, 7(5), 1995, pp. 420-423
40. JENSEN BO; HOLMSEN H
    NITRIC-OXIDE (NO)-PLATELET INTERACTIONS - INHIBITION IS INDEPENDENT OF THE PROSTANOID AND ADP PATHWAYS
    Platelets
    
    B.O. Jensen e H. Holmsen, "NITRIC-OXIDE (NO)-PLATELET INTERACTIONS - INHIBITION IS INDEPENDENT OF THE PROSTANOID AND ADP PATHWAYS", Platelets, 6(2), 1995, pp. 83-90
41. REUTER HD
    ALLIUM-SATIVUM AND ALLIUM-URSINUM .2. PHARMACOLOGY AND MEDICINAL APPLICATION
    Phytomedicine
    
    H.D. Reuter, "ALLIUM-SATIVUM AND ALLIUM-URSINUM .2. PHARMACOLOGY AND MEDICINAL APPLICATION", Phytomedicine, 2(1), 1995, pp. 73-91
42. TOZZICIANCARELLI MG; DIMASSIMO C; TOZZI E; MASCIOLI A; DEMATTEIS G; CAROLEI A
    INFLUENCE OF A SELECTIVE 5HT(1)-RECEPTOR AGONIST GR43175 ON PLATELET RESPONSIVENESS
    Cephalalgia
    
    M.G. Tozziciancarelli et al., "INFLUENCE OF A SELECTIVE 5HT(1)-RECEPTOR AGONIST GR43175 ON PLATELET RESPONSIVENESS", Cephalalgia, 15(6), 1995, pp. 472-476
43. NUMAZAWA R; YOSHIOKA M; MATSUMOTO M; TOGASHI H; KEMMOTSU O; SAITO H
    PHARMACOLOGICAL CHARACTERIZATION OF ALPHA(2)-ADRENOCEPTOR REGULATED SEROTONIN RELEASE IN THE RAT HIPPOCAMPUS
    Neuroscience letters
    
    R. Numazawa et al., "PHARMACOLOGICAL CHARACTERIZATION OF ALPHA(2)-ADRENOCEPTOR REGULATED SEROTONIN RELEASE IN THE RAT HIPPOCAMPUS", Neuroscience letters, 192(3), 1995, pp. 161-164
44. DEMINA OV; VRZHESHCH PV; KHODONOV AA; KOZLOVSKII VI; VARFOLOMEEV SD
    SYNTHESIS OF SUBSTITUTED PYRIDYLISOXAZOLE S AND THEIR 4,5-DIHYDRO ANALOGS - NOVEL INHIBITORS OF THROMBOCYTE AGGREGATION
    Bioorganiceskaa himia
    
    O.V. Demina et al., "SYNTHESIS OF SUBSTITUTED PYRIDYLISOXAZOLE S AND THEIR 4,5-DIHYDRO ANALOGS - NOVEL INHIBITORS OF THROMBOCYTE AGGREGATION", Bioorganiceskaa himia, 21(12), 1995, pp. 933-940
45. PENG JP; YAO XS; KOBAYASHI H; MA CY
    NOVEL FUROSTANOL GLYCOSIDES FROM ALLIUM MACROSTEMON
    Planta medica
    
    J.P. Peng et al., "NOVEL FUROSTANOL GLYCOSIDES FROM ALLIUM MACROSTEMON", Planta medica, 61(1), 1995, pp. 58-61
46. LIN HB; YOUNG DB
    OPPOSING EFFECTS OF PLASMA EPINEPHRINE AND NOREPINEPHRINE ON CORONARY-THROMBOSIS IN-VIVO
    Circulation
    
    H.B. Lin e D.B. Young, "OPPOSING EFFECTS OF PLASMA EPINEPHRINE AND NOREPINEPHRINE ON CORONARY-THROMBOSIS IN-VIVO", Circulation, 91(4), 1995, pp. 1135-1142
47. BERTOLINO F; VALENTIN JP; MAFFRE M; GRELAC F; BESSAC AM; MACLOUF J; DELHON A; LEVYTOLEDANO S; PATOISEAU JF; COLPAERT FC; JOHN GW
    INTRINSIC ACTIVITY OF THE NONPROSTANOID THROMBOXANE A(2) RECEPTOR ANTAGONIST, DALTROBAN (BM-13,505), IN HUMAN PLATELETS IN-VITRO AND IN THERAT VASCULATURE IN-VIVO
    British Journal of Pharmacology
    
    F. Bertolino et al., "INTRINSIC ACTIVITY OF THE NONPROSTANOID THROMBOXANE A(2) RECEPTOR ANTAGONIST, DALTROBAN (BM-13,505), IN HUMAN PLATELETS IN-VITRO AND IN THERAT VASCULATURE IN-VIVO", British Journal of Pharmacology, 115(1), 1995, pp. 210-216
48. BEUKERS MW; KERKHOF CJM; IJZERMAN AP; SOUDIJN W
    NUCLEOSIDE TRANSPORT INHIBITION AND PLATELET-AGGREGATION IN HUMAN BLOOD - R75231 AND ITS ENANTIOMERS, DRAFLAZINE AND R88016
    European journal of pharmacology. Molecular pharmacology section
    
    M.W. Beukers et al., "NUCLEOSIDE TRANSPORT INHIBITION AND PLATELET-AGGREGATION IN HUMAN BLOOD - R75231 AND ITS ENANTIOMERS, DRAFLAZINE AND R88016", European journal of pharmacology. Molecular pharmacology section, 266(1), 1994, pp. 57-62
49. BERKELS R; KLAUS W; BOLLER M; ROSEN R
    THE CALCIUM MODULATOR NIFEDIPINE EXERTS ITS ANTIAGGREGATORY PROPERTY VIA A NITRIC-OXIDE MEDIATED PROCESS
    Thrombosis and haemostasis
    
    R. Berkels et al., "THE CALCIUM MODULATOR NIFEDIPINE EXERTS ITS ANTIAGGREGATORY PROPERTY VIA A NITRIC-OXIDE MEDIATED PROCESS", Thrombosis and haemostasis, 72(2), 1994, pp. 309-312
50. LIN HB; YOUNG DB
    INTERACTION BETWEEN PLASMA POTASSIUM AND EPINEPHRINE IN CORONARY-THROMBOSIS IN DOGS
    Circulation
    
    H.B. Lin e D.B. Young, "INTERACTION BETWEEN PLASMA POTASSIUM AND EPINEPHRINE IN CORONARY-THROMBOSIS IN DOGS", Circulation, 89(1), 1994, pp. 331-338
51. WERNS SW; ROTE WE; DAVIS JH; GUEVARA T; LUCCHESI BR
    NITROGLYCERIN INHIBITS EXPERIMENTAL THROMBOSIS AND REOCCLUSION AFTER THROMBOLYSIS
    The American heart journal
    
    S.W. Werns et al., "NITROGLYCERIN INHIBITS EXPERIMENTAL THROMBOSIS AND REOCCLUSION AFTER THROMBOLYSIS", The American heart journal, 127(4), 1994, pp. 727-737
52. IGNARRO LJ
    NITRIC OXIDE-MEDIATED VASORELAXATION
    Thrombosis and haemostasis
    
    L.J. Ignarro, "NITRIC OXIDE-MEDIATED VASORELAXATION", Thrombosis and haemostasis, 70(1), 1993, pp. 148-151
53. GLUSA E; RICHTER M; AMON I
    ACTIVATION OF HUMAN BLOOD-PLATELETS INDUCED BY NOCLOPROST, A STABLE PROSTAGLANDIN-E(2) DERIVATIVE
    Haemostasis
    
    E. Glusa et al., "ACTIVATION OF HUMAN BLOOD-PLATELETS INDUCED BY NOCLOPROST, A STABLE PROSTAGLANDIN-E(2) DERIVATIVE", Haemostasis, 23(4), 1993, pp. 203-211
54. BARRE DE; HOLUB BJ; CHAPKIN RS
    THE EFFECT OF BORAGE OIL SUPPLEMENTATION ON HUMAN PLATELET-AGGREGATION, THROMBOXANE-B(2), PROSTAGLANDIN-E(1) AND PROSTAGLANDIN-E(2) FORMATION
    Nutrition research
    
    D.E. Barre et al., "THE EFFECT OF BORAGE OIL SUPPLEMENTATION ON HUMAN PLATELET-AGGREGATION, THROMBOXANE-B(2), PROSTAGLANDIN-E(1) AND PROSTAGLANDIN-E(2) FORMATION", Nutrition research, 13(7), 1993, pp. 739-751
55. MATHEWS WR; KERR SW
    BIOLOGICAL-ACTIVITY OF S-NITROSOTHIOLS - THE ROLE OF NITRIC-OXIDE
    The Journal of pharmacology and experimental therapeutics
    
    W.R. Mathews e S.W. Kerr, "BIOLOGICAL-ACTIVITY OF S-NITROSOTHIOLS - THE ROLE OF NITRIC-OXIDE", The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1529-1537
56. JAIN MK; APITZCASTRO R
    GARLIC - A PRODUCT OF SPILLED AMBROSIA
    Current Science
    
    M.K. Jain e R. Apitzcastro, "GARLIC - A PRODUCT OF SPILLED AMBROSIA", Current Science, 65(2), 1993, pp. 148-156
57. TANAKA T; MORISHIMA Y; WATANABE K; SHIBUTANI T; YASUOKA M; SHIBANO T
    COMBINED EFFECT OF THE 5-HT(2) RECEPTOR ANTAGONIST DV-7028 AND ASPIRIN OR HEPARIN ON CORONARY CYCLIC FLOW REDUCTIONS IN DOGS
    Cardiovascular Research
    
    T. Tanaka et al., "COMBINED EFFECT OF THE 5-HT(2) RECEPTOR ANTAGONIST DV-7028 AND ASPIRIN OR HEPARIN ON CORONARY CYCLIC FLOW REDUCTIONS IN DOGS", Cardiovascular Research, 27(7), 1993, pp. 1374-1379
58. MERRYMAN PF; CLANCY RM; HE XY; ABRAMSON SB
    MODULATION OF HUMAN T-CELL RESPONSES BY NITRIC-OXIDE AND ITS DERIVATIVE, S-NITROSOGLUTATHIONE
    Arthritis and rheumatism
    
    P.F. Merryman et al., "MODULATION OF HUMAN T-CELL RESPONSES BY NITRIC-OXIDE AND ITS DERIVATIVE, S-NITROSOGLUTATHIONE", Arthritis and rheumatism, 36(10), 1993, pp. 1414-1422
59. SENDL A; ELBL G; STEINKE B; REDL K; BREU W; WAGNER H
    COMPARATIVE PHARMACOLOGICAL INVESTIGATIONS OF ALLIUM-URSINUM AND ALLIUM-SATIVUM
    Planta medica
    
    A. Sendl et al., "COMPARATIVE PHARMACOLOGICAL INVESTIGATIONS OF ALLIUM-URSINUM AND ALLIUM-SATIVUM", Planta medica, 58(1), 1992, pp. 1-7